Multiple binding mode of reversible synthetic thrombin inhibitors. A comparative structural analysis

Area of Science:

• Biochemistry
• Pharmacology
• Molecular Biology

Background:

• Thrombin, a serine protease, is crucial in hemostasis and thrombosis.
• Developing potent and selective thrombin inhibitors is a key research area.
• Understanding thrombin-inhibitor interactions informs the design of novel antithrombotic agents.

Purpose of the Study:

• To provide a comparative overview of current reversible thrombin inhibitors.
• To discuss structural factors influencing thrombin-inhibitor binding affinity and potency.
• To introduce a novel class of synthetic, multisite-directed thrombin inhibitors (hirunorms).

Main Methods:

• Comparative analysis of existing reversible thrombin inhibitors.
• Structural analysis of thrombin-inhibitor complexes.
• Design and development of hirunorms, mimicking hirudin's binding.
• Investigating diverse binding mechanisms within the thrombin active site.

Main Results:

• Existing reversible thrombin inhibitors exhibit varying affinities and potencies.
• Structural insights reveal key determinants of thrombin-inhibitor interactions.
• Hirunorms demonstrate a novel approach to multisite-directed inhibition.
• Thrombin active site interactions with inhibitors can occur via multiple mechanisms.

Conclusions:

• Reversible thrombin inhibitors are vital for managing hemostasis and thrombosis.
• Structural understanding facilitates the design of more effective antithrombotic drugs.
• Hirunorms represent a promising new class of synthetic thrombin inhibitors.
• The specificity of thrombin does not preclude diverse inhibitor binding mechanisms.